Production (Stage)
Raia Drogasil S.A.
RADLY
$2.47
-$0.17-6.44%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -6.59% | -4.29% | 1.28% | 9.03% | 20.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.59% | -4.29% | 1.28% | 9.03% | 20.43% |
| Cost of Revenue | -5.89% | -3.64% | 1.44% | 10.05% | 20.52% |
| Gross Profit | -8.30% | -5.80% | 0.89% | 6.73% | 20.21% |
| SG&A Expenses | -4.46% | -5.63% | -2.38% | 8.31% | 18.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -5,434.94% | 140.85% | 149.63% | 518.21% | 117.90% |
| Total Operating Expenses | -5.92% | -2.94% | 1.30% | 9.75% | 20.01% |
| Operating Income | -17.62% | -24.79% | 0.87% | -0.05% | 27.66% |
| Income Before Tax | -39.48% | -20.00% | 28.49% | -5.09% | 44.41% |
| Income Tax Expenses | -65.57% | -442.88% | 165.86% | 13.12% | 1,550.34% |
| Earnings from Continuing Operations | -27.78% | 6.00% | 11.24% | -8.98% | 2.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 82.86% | 100.59% | 19.08% | 60.37% | 0.01% |
| Net Income | -26.17% | 13.04% | 11.76% | -8.23% | 2.53% |
| EBIT | -17.62% | -24.79% | 0.87% | -0.05% | 27.66% |
| EBITDA | -14.98% | -20.61% | -0.56% | 0.22% | 23.89% |
| EPS Basic | -26.09% | 17.59% | 14.38% | -46.32% | 6.48% |
| Normalized Basic EPS | -28.02% | -26.61% | 11.50% | -40.75% | 53.33% |
| EPS Diluted | -25.55% | 17.59% | 13.75% | -46.32% | 7.08% |
| Normalized Diluted EPS | -27.32% | -26.61% | 10.62% | -40.75% | 55.30% |
| Average Basic Shares Outstanding | -0.15% | -3.84% | -2.33% | 71.24% | -3.79% |
| Average Diluted Shares Outstanding | -0.80% | -3.84% | -1.74% | 71.24% | -4.70% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.40% | -0.26% | 1.89% | 0.09% | 7.67% |